September 18, 2024
Altamira Therapeutics Announces Pricing of up to $12.0 Million Public Offering
Hamilton, Bermuda, Sept. 17, 2024 (GLOBE NEWSWIRE) — $4 million upfront with up to an additional $8 million of aggregate…
Pharmaceuticals, Biotechnology and Life Sciences
Hamilton, Bermuda, Sept. 17, 2024 (GLOBE NEWSWIRE) — $4 million upfront with up to an additional $8 million of aggregate…
MONTREAL, Sept. 17, 2024 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company…
LOS ANGELES, Sept. 17, 2024 (GLOBE NEWSWIRE) — Kairos Pharma, Ltd. (“Kairos Pharma” or the “Company”) (NYSE American: KAPA), a…
SOUTH SAN FRANCISCO, Calif., Sept. 17, 2024 (GLOBE NEWSWIRE) — The independent directors of the Board of 23andMe Holding Co.…
SAN FRANCISCO, Sept. 17, 2024 (GLOBE NEWSWIRE) — Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel…
Brennan Clark Joins Fairway Consulting Group Brennan Clark Joins Fairway Consulting Group as Vice President of Executive Search NEW YORK,…
Ad hoc announcement pursuant to Art. 53 LR Broad indication in HR+/HER2- stage II and III early breast cancer (EBC)…
Allschwil, Switzerland – September 17, 2024 Idorsia Ltd (SIX: IDIA) today announced that new data and analyses of daridorexant, Idorsia’s…
NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) — Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new…
WINTER PARK, Fla., Sept. 17, 2024 (GLOBE NEWSWIRE) — ADIA Nutrition Inc. (OTC Pink: ADIA) has announced the hiring of…